TestSmart and toxic ignorance

Alternatives to Laboratory Animals

Volumn 32, Issue SUPPL. 1A, 2004, Pages 359-363

  Green, Sidney ^a   Goldberg, Alan M ^b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Alternatives; Endocrine disruptors; High Production Volume (HPV); REACH; TestSmart; Tier testing; Toxicity screening

Indexed keywords

INDUSTRIAL CHEMICAL;

CHILD HEALTH; CONFERENCE PAPER; DECISION THEORY; ECOTOXICITY; ENDOCRINE DISEASE; EVALUATION; GENOMICS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGISTRATION; SAFETY; SCREENING; TOXICITY TESTING; TOXICOLOGY;

EID: 3042517737     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290403201s59     Document Type: Conference Paper

References (13)

1. Cross, D.M. & Bayliss, M.K. (2000). A commentary on the use of hepatocytes in drug metabolism studies during drug discovery and development. Drug Metabolism Reviews 32, 219-240.
2. Waring, J.F. & Ulrich, R.G. (2000). The impact of genomics-based technologies on drug safety evaluation. Annual Review of Pharmacology and Toxicology 40, 335-352.
3. Green, S. & Goldberg, A.M. (2001). TestSmart-High Production Volume Chemicals: an approach to implementing alternatives into regulatory toxicology. Toxicological Sciences 63, 6-14.
4. Gandolphi, A.L., Brendel, K., Fisher, R.L. & Michaud, J.P. (1995). Use of tissue slices in chemical mixture toxicology and interspecies investigations. Toxicology 105, 285-290.
5. Chan, E.M., Thomas, M.J., Bandy, B. & Tibbits, G.F. (1996). Effects of doxorubicin, 4-epirubicin, and antioxidant enzymes on the contractility of isolated cardiomyocytes. Canadian Journal of Physiology and Pharmacology 74, 904-910.
6. Horwitz, L.D., Wallner, J.S., Decker, D.E. & Buxser, S.E. (1996). Efficacy of lipid soluble, membrane-protective agents against hydrogen peroxide cytotoxicity in cardiac myocytes. Free Radical Biology and Medicine 21, 743-753.
7. Poliquin, J.F. & Crepeau, J. (1985). Immune defense mechanisms of the nasal mucosa. Journal of Otolaryngology 14, 80-84.
8. Hukkanen, J., Lassila, A., Paivarinta, K., Valanne, S., Sarpo, S., Jakkola, J.K., Pelkonen, O. & Raunio, H. (2000). Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. American Journal of Respiratory Cell and Molecular Biology 22, 360-366.
9. Chapin, R.E., Sloane, R.A. & Haseman, J.K. (1998). Reproductive endpoints in general toxicity studies: are they predictive? Reproductive Toxicology 12, 489-494.
10. Pfaller, W. & Gstraunthaler (1998). Nephrotoxicity testing in vitro - what we know and what we need to know. Environmental Health Perspectives 106, (Suppl. 2), 559-569.
11. Hamadeh, H.K., Bushel, P.R., Jayadev, S., DiSorbo, O., Bennett, L., Li, L., Tennant, R., Stoll, R., Barrett, J.C., Paules, R.S., Blanchard, K. & Afshari, C.A. (2002). Prediction of compound signature using high density gene expression profiling. Toxicological Sciences 67, 232-240.
12. Man, W.J., White, J.R., Bryant, D., Bugelski, P., Camilleri, P., Cutler, P., Heald, G., Lork, P.G. & Kramer, K. (2002). Protein expression analysis of drug-mediated hepatotoxicity in the Sprague-Dawley rat. Proteomics 2, 1577-1585.
13. Nicholson, J.K., Connelly, J., Lindon, J.C. & Holmes, E. (2002). Metabonomics: a platform for studying drug toxicity and gene function. Nature Reviews Drug Discovery 1, 153-161.